Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APP | P05067 | 10/20 | 0.59 |
| ▸ | GLA | P06280 | 1/20 | 0.57 |
| ▸ | GAA | P10253 | 1/20 | 0.57 |
| ▸ | SULT1A1 | P50225 | 1/20 | 0.53 |
| ▸ | SNCA | P37840 | 1/20 | 0.51 |
| ▸ | ATP4A | P20648 | 1/20 | 0.51 |
| ▸ | ATP4B | P51164 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1983586 | 1.00 | APP (0.59) | APPGLAGAASULT1A1SNCA | |
| SCHEMBL1985902 | 0.91 | APP (0.59) | APPGLAGAASULT1A1SNCA | |
| SCHEMBL1985906 | 0.91 | APP (0.59) | APPGLAGAASULT1A1SNCA | |
| SCHEMBL1986282 | 0.90 | APP (0.61) | APPGLAGAASULT1A1SNCA | |
| SCHEMBL1986280 | 0.90 | APP (0.61) | APPGLAGAASULT1A1SNCA | |
| SCHEMBL16256425 | 0.85 | APP (0.53) | APPGLAGAASULT1A1SNCA | |
| SCHEMBL1984042 | 0.83 | SULT1A1 (0.72) | APPGLAGAASULT1A1SNCA | |
| SCHEMBL1984039 | 0.83 | SULT1A1 (0.72) | APPGLAGAASULT1A1SNCA | |
| SCHEMBL21566066 | 0.82 | APP (0.69) | APPGLAGAASULT1A1SNCA | |
| SCHEMBL5429982 | 0.80 | APP (0.83) | APPGLAGAASULT1A1SNCA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2338059-B1 | Ligands for aggregated tau molecules | WISTA LAB LTD (SG) | 2015-04-08 | — | — | EP | disclosed |
| US-8895313-B2 | Ligands for aggregated tau molecules | WISTA LABORATORIES LTD. (SG) | 2014-11-25 | — | — | US | disclosed |
| US-20110171739-A1 | LIGANDS FOR AGGREGATED TAU MOLECULES | WISTA LABORATORIES LTD. | 2011-07-14 | — | — | US | disclosed |
| EP-2338059-A1 | LIGANDS FOR AGGREGATED TAU MOLECULES | Wista Laboratories Ltd. (SG) | 2011-06-29 | — | — | EP | disclosed |
| WO-2010034982-A1 | LIGANDS FOR AGGREGATED TAU MOLECULES | WISTA LABORATORIES LTD. (SG) | 2010-04-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110171739-A1 | LIGANDS FOR AGGREGATED TAU MOLECULES | MAPT, PRNP, MAP4 | APP 17/4885GLA 1532/4885GAA 1252/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.